Citations

Clear

4610 citation(s) found for "Lu, Brian".

Teaching Neuro Images : “Pancake-like” gadolinium enhancement suggests compressive myelopathy due to spondylosis
Marsh, Richard W., Flanagan, Eoin P. , Weinshenker, Brian G.

Mayo Clinic

Neurology | April 21, 2023 | Volume: 100 | Issue: 16_supplement_1 | Pages: No page available

10.1212/wnl.0000000000207025 Get It

Teaching NeuroImages: Texting rhythm
Hanrahan, Brian , Tatum, William O.

Mayo Clinic

Neurology | April 21, 2023 | Volume: 100 | Issue: 16_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206925 Get It

Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis
Wang, YunZu Michele , Abdullah, Sheyar , Luebbering, Nathan, Langenberg, Lucille, Duell, Alexandra, Lake, Kelly E. , Lane, Adam , Hils, Brian, Silva, O., Trapp, Monica, Koo, Jane , Denson, Lee A. , Jodele, Sonata , Haslam, David , Faubion, William A. , Lake, Kelly , Nalapareddy, Kodandaramireddy , Koo, Jane , Haslam, David B , Davies, Stella M , Khandelwal, Pooja

Mayo Clinic

Blood Advances | April 21, 2023 | Volume: 7 | Issue: 17 | Pages: 5137-5151

10.1182/bloodadvances.2023009960 | PMID 37083597 Get It

Abstract Intestinal permeability may correlate with adverse outcomes during hematopoietic stem cell transplantation (HSCT), but longitudinal quantification with traditional oral mannitol and lactulose is not feasible in HSCT recipients because of mucositis and diarrhea. A modified lactulose:rhamnose (LR) assay is validated in children with environmental enteritis. Our study objective was to quantify peri-HSCT intestinal permeability changes using the modified LR assay. The LR assay was administered before transplant, at day +7 and +30 to 80 pediatric and young adult patients who received allogeneic HSCT. Lactulose and rhamnose were detected using urine mass spectrometry and expressed as an L:R ratio. Metagenomic shotgun sequencing of stool for microbiome analyses and enzyme-linked immunosorbent assay analyses of plasma lipopolysaccharide binding protein (LBP), ST2, REG3α, claudin1, occludin, and intestinal alkaline phosphatase were performed at the same timepoints. L:R ratios were increased at day +7 but returned to baseline at day +30 in most patients (P = .014). Conditioning regimen intensity did not affect the trajectory of L:R (P = .39). Baseline L:R ratios did not vary with diagnosis. L:R correlated with LBP levels (r2 = 0.208; P = .0014). High L:R ratios were associated with lower microbiome diversity (P = .035), loss of anaerobic organisms (P = .020), and higher plasma LBP (P = .0014). No adverse gastrointestinal effects occurred because of LR. Intestinal permeability as measured through L:R ratios after allogeneic HSCT correlates with intestinal dysbiosis and elevated plasma LBP. The LR assay is well-tolerated and may identify transplant recipients who are more likely to experience adverse outcomes.
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization
Luebker, Sarah, Frech, Tracy , Skaug, Brian , Gordon, Jessica , Lakin, Kimberly S. , Bernstein, Elana J. , Luo, Yiming , Steen, Virginia , Moore, Duncan F. , Khanna, Dinesh , Castelino, Flavia V. , Chung, Lorinda, Kapoor, Puneet, Hant, Faye N. , Shanmugam, Victoria K. , VanBuren, John M. , Alvey, Jessica S. , Harding, Monica, Shah, Ankoor R. , Lebiedz‐Odrobina, Dorota, Thomas, Julie K. , Volkmann, Elizabeth R. , Molitor, Jerry A., Sandorfi, Nora , Chung, Leland W.K. , Luo, Yiming , Frech, Tracy M , Skaug, Brian , Bernstein, Elana J , Richardson, Carrie , Khanna, Dinesh , Volkmann, Elizabeth R , Chung, Lorinda , Luo, Yiming , Assassi, Shervin , Luo, Yiming, Shah, Ami A. , Hummers, Laura K , Chung, Lorinda, Shah, Ankoor, Makol, Ashima , Thomas, Julie K

Mayo Clinic

Rheumatology | April 20, 2023 | Volume: 62 | Issue: 10 | Pages: 3433-3438

10.1093/rheumatology/kead176 | PMID 37079727 Get It

Abstract Objectives SSc is associated with increased health-care resource utilization and economic burden. The Collaborative National Quality and Efficacy Registry (CONQUER) is a US-based collaborative that collects longitudinal follow-up data on SSc patients with <5 years of disease duration enrolled at scleroderma centres in the USA. The objective of this study was to investigate the relationship between gastrointestinal tract symptoms and self-reported resource utilization in CONQUER participants. Methods CONQUER participants who had completed a baseline and 12-month Gastrointestinal Tract Questionnaire (GIT 2.0) and a Resource Utilization Questionnaire (RUQ) were included in this analysis. Patients were categorized by total GIT 2.0 severity: none-to-mild (0–0.49); moderate (0.50–1.00), and severe-to-very severe (1.01–3.00). Clinical features and medication exposures were examined in each of these categories. The 12-month RUQ responses were summarized by GIT 2.0 score categories at 12 months. Results Among the 211 CONQUER participants who met the inclusion criteria, most (64%) had mild GIT symptoms, 26% had moderate symptoms, and 10% severe GIT symptoms at 12 months. The categorization of GIT total severity score by RUQ showed that more upper endoscopy procedures and inpatient hospitalization occurred in the CONQUER participants with severe GIT symptoms. These patients with severe GIT symptoms also reported the use of more adaptive equipment. Conclusion This report from the CONQUER cohort suggests that severe GIT symptoms result in more resource utilization. It is especially important to understand resource utilization in early disease cohorts when disease activity, rather than damage, primarily contributes to health-related costs of SSc.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Duong, Vu H. , Ruppert, Amy S. , Borate, Uma , Stein, Eytan M. , Baer, Maria R. , Kovacsovics, Tibor , Blum, William , Arellano, Martha , Schiller, Gary J. , Olin, Rebecca L. , Foran, James M. , Litzow, Mark R. , Patel, Prapti A. , Redner, Robert L. , Al‐Mansour, Zeina , Swords, Ronan , Collins, Robert H. , Vergilio, Jo‐Anne, Heerema, Nyla A. , Rosenberg, Leonard, Yocum, Ashley O. , Marcus, Sonja, Druggan, Franchesca , Stefanos, Mona , Gana, Theophilus J. , Burd, Amy , Byrd, John C. , Levine, Ross L. , Boyiadzis, Michael , Byrd, John C. , Blum, William , Arellano, Martha L , Foran, James M , Lin, Tara L , Gana, Theophilus J , Duong, Vu H , Byrd, John C , Mims, Alice S , Stock, Wendy , Lin, Tara L. , Foster, Matthew C , Cogle, Christopher Ramin , Chen, Timothy Frank , Shoben, Abigail B. , Druker, Brian J

Mayo Clinic

Cancer | April 20, 2023 | Volume: 129 | Issue: 15 | Pages: 2308-2320

10.1002/cncr.34780 | PMID 37078412 Get It

AbstractBackgroundPatients with acute myeloid leukemia (AML) who have tumor protein p53 (TP53) mutations or a complex karyotype have a poor prognosis, and hypomethylating agents are often used. The authors evaluated the efficacy of entospletinib, an oral inhibitor of spleen tyrosine kinase, combined with decitabine in this patient population.MethodsThis was a multicenter, open‐label, phase 2 substudy of the Beat AML Master Trial (ClinicalTrials.gov identifier NCT03013998) using a Simon two‐stage design. Eligible patients aged 60 years or older who had newly diagnosed AML with mutations in TP53 with or without a complex karyotype (cohort A; n = 45) or had a complex karyotype without TP53 mutation (cohort B; n = 13) received entospletinib 400 mg twice daily with decitabine 20 mg/m2 on days 1–10 every 28 days for up to three induction cycles, followed by up to 11 consolidation cycles, in which decitabine was reduced to days 1–5. Entospletinib maintenance was given for up to 2 years. The primary end point was complete remission (CR) and CR with hematologic improvement by up to six cycles of therapy.ResultsThe composite CR rates for cohorts A and B were 13.3% (95% confidence interval, 5.1%–26.8%) and 30.8% (95% confidence interval, 9.1%–61.4%), respectively. The median duration of response was 7.6 and 8.2 months, respectively, and the median overall survival was 6.5 and 11.5 months, respectively. The study was stopped because the futility boundary was crossed in both cohorts.ConclusionsThe combination of entospletinib and decitabine demonstrated activity and was acceptably tolerated in this patient population; however, the CR rates were low, and overall survival was short. Novel treatment strategies for older patients with TP53 mutations and complex karyotype remain an urgent need.
Artificial Intelligence: Singularity Approaches
TerKonda, Sarvam P. , TerKonda, Anurag A., Sacks, Justin M. , Kinney, Brian M. , Gurtner, Geoff C., Nachbar, James M., Reddy, Sashank , Jeffers, Lynn L., Jeffers, Lynn

Mayo Clinic

Plastic & Reconstructive Surgery | April 19, 2023 | Volume: 153 | Issue: 1 | Pages: 204e-217e

10.1097/prs.0000000000010572 | PMID 37075274 Get It

Summary: Artificial intelligence (AI) has been a disruptive technology within health care, from the development of simple care algorithms to complex deep-learning models. AI has the potential to reduce the burden of administrative tasks, advance clinical decision-making, and improve patient outcomes. Unlocking the full potential of AI requires the analysis of vast quantities of clinical information. Although AI holds tremendous promise, widespread adoption within plastic surgery remains limited. Understanding the basics is essential for plastic surgeons to evaluate the potential uses of AI. This review provides an introduction of AI, including the history of AI, key concepts, applications of AI in plastic surgery, and future implications.
Self-Triage Use, Subsequent Healthcare Utilization, and Diagnoses: A Retrospective Study of Process and Clinical Outcomes Following Self-Triage and Self-Scheduling for Ear or Hearing Symptoms
North, Frederick , Jensen, Teresa B. , Stroebel, Robert J. , Nelson, Elissa M , Johnson, Brenda J , Thompson, Matthew C , Pecina, Jennifer L. , Crum, Brian A. , Pecina, Jennifer , Crum, Brian A , Thompson, Matthew C

Mayo Clinic

Health Services Research and Managerial Epidemiology | April 19, 2023 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/23333928231168121 | PMID 37101803 Get It

Background Self-triage is becoming more widespread, but little is known about the people who are using online self-triage tools and their outcomes. For self-triage researchers, there are significant barriers to capturing subsequent healthcare outcomes. Our integrated healthcare system was able to capture subsequent healthcare utilization of individuals who used self-triage integrated with self-scheduling of provider visits. Methods We retrospectively examined healthcare utilization and diagnoses after patients had used self-triage and self-scheduling for ear or hearing symptoms. Outcomes and counts of office visits, telemedicine interactions, emergency department visits, and hospitalizations were captured. Diagnosis codes associated with subsequent provider visits were dichotomously categorized as being associated with ear or hearing concerns or not. Nonvisit care encounters of patient-initiated messages, nurse triage calls, and clinical communications were also captured. Results For 2168 self-triage uses, we were able to capture subsequent healthcare encounters within 7 days of the self-triage for 80.5% (1745/2168). In subsequent 1092 office visits with diagnoses, 83.1% (891/1092) of the uses were associated with relevant ear, nose and throat diagnoses. Only 0.24% (4/1662) of patients with captured outcomes were associated with a hospitalization within 7 days. Self-triage resulted in a self-scheduled office visit in 7.2% (126/1745). Office visits resulting from a self-scheduled visit had significantly fewer combined non-visit care encounters per office visit (fewer combined nurse triage calls, patient messages, and clinical communication messages) than office visits that were not self-scheduled (−0.51; 95% CI, −0.72 to −0.29; P < .0001). Conclusion In an appropriate healthcare setting, self-triage outcomes can be captured in a high percentage of uses to examine for safety, patient adherence to recommendations, and efficiency of self-triage. With the ear or hearing self-triage, most uses had subsequent visit diagnoses relevant to ear or hearing, so most patients appeared to be selecting the appropriate self-triage pathway for their symptoms.
Do bone elasticity and postmortem interval affect forensic fractographic analyses?
Skinner, Jessica , Joseph, Malin, Herrick, James L., Brown, Robert D. , Waletzki, Brian E., Goguen, Peter, Rajan, Subramaniam , Langley, Natalie, Herrick, James, Langley, Natalie R. , Shyamsunder, Loukham

Mayo Clinic

Journal of Forensic Sciences | April 14, 2023 | Volume: 68 | Issue: 3 | Pages: 757-767

10.1111/1556-4029.15237 | PMID 37057637 Get It

AbstractForensic fractographic features of bone reliably establish crack propagation in perimortem injuries. We investigated if similar fracture surface features characterize postmortem fractures. Experimentally induced peri‐ and postmortem fractures were used to assess if fractographic features vary as bone elasticity decreases during the postmortem interval (PMI). Thirty‐seven unembalmed, defleshed human femoral shafts from males and females aged 33–81 years were fractured at varying PMIs with a drop test frame using a three‐point bending setup and recorded with a high‐speed camera. Vital statistics, cause of death, PMI length, temperature, humidity, collagen percentage, water loss, fracture energy, and fractography scores were recorded for each sample. Results showed that fractographic features associated with perimortem fractures were expressed in PMIs up to 40,600 accumulated degree hours (ADH), or 60 warm weather days. Hackle was the most consistently expressed feature, occurring in all fractures regardless of ADH. The most variable characteristics were wake features (78.4%) and arrest ridges (70.3%). Collagen percentage did not correlate strongly with ADH (r = −0.04, p = 0.81); however, there was a strong significant correlation between ADH and water loss (r = 0.74, p < 0.001). Multinomial logistic regression showed no association between fractographic feature expression and ADH or collagen percentage. In conclusion, forensic fractographic features reliably determine initiation and directionality of crack propagation in experimentally induced PMIs up to 40,600 ADH, demonstrating the utility of this method into the recent postmortem interval. This expression of reliable fractographic features throughout the early PMI intimates these characteristics may not be useful standalone features for discerning peri‐ versus postmortem fractures.
Is Bone Marrow Aspiration and Biopsy of Clinical Importance in the Initial Staging of Extraskeletal Ewing Sarcoma?
Wahlig, Brian D. , Rose, Peter S. , Broida, Samuel E. , Robinson, Steven I. , Siontis, Brittany L. , Houdek, Matthew T.

Mayo Clinic

Clinical Orthopaedics & Related Research | April 13, 2023 | Volume: 481 | Issue: 11 | Pages: 2177-2182

10.1097/corr.0000000000002661 | PMID 37053072 Get It

Abstract Background Extraskeletal Ewing sarcoma are rare tumors within the Ewing sarcoma family. Initial staging studies for extraskeletal Ewing sarcoma historically have included imaging and bone marrow aspiration and biopsy (BMAB). However, recent studies on Ewing sarcoma of bone have questioned the utility of BMAB in the initial staging of patients, but no studies of which we are aware have evaluated the role of BMAB in extraskeletal Ewing sarcoma. We suspected that BMAB was of low diagnostic yield in patients with extraskeletal Ewing sarcoma and exposed patients to potential morbidity without an impact on their clinical course. Question/purpose Is BMAB a useful test in the staging of extraskeletal Ewing sarcoma? Methods Between January 1996 and December 2021, our institution evaluated 109 patients with a listed diagnosis of extraskeletal Ewing sarcoma. Those patients were retrospectively reviewed for this study. Of those, we considered patients with biopsy-confirmed diagnosis of extraskeletal Ewing sarcoma. Biopsy was performed based on institutional protocols, with all diagnoses assigned by a board-certified pathologist. Based on that criteria, 96% (105 of 109) were eligible. An additional 18% (20 of 109) were excluded because records of their initial diagnostic and staging workup were not available. This left 78% (85 of 109) for analysis. Of those, 52% (44 of 85) were male. The average age was 32 ± 16 years. Primary tumor locations included extremities in 26% (22 of 85), paraspinal in 20% (17 of 85), chest in 19% (16 of 85), retroperitoneum in 13% (11 of 85), intraabdominal in 12% (10 of 85), intrapelvic in 7% (6 of 85), and head or neck in 4% (3 of 85). Initial diagnostic and staging information, including the use of PET-CT, bone scan, CT chest, and BMAB, was collected. Metastatic disease at the time of presentation or during follow-up was noted. The utility of BMAB was determined by the rate of positive tests in those undergoing BMAB during the initial staging process. Descriptive statistical analysis was sufficient to address the study question, and therefore no comparative statistics were performed. Results BMAB was obtained during the initial staging process in 64% (54 of 85) of patients. This BMAB was negative in all 54 patients, including those with known metastatic disease. Conclusion Diagnosing metastatic disease in extraskeletal Ewing sarcoma is important as the presence of metastases at diagnosis adversely affects prognosis. The routine use of BMAB in the staging process of extraskeletal Ewing sarcoma is of low diagnostic yield. BMAB is unlikely to diagnose metastatic involvement even in patients with known metastases to bone. We do not have enough data to suggest whether other modalities, such as PET-CT, might be more useful. Similar studies should be pursued to determine the utility of the remainder of staging modalities in patients with extraskeletal Ewing sarcoma to elucidate the most efficient and effective staging protocol. Level of Evidence Level III, diagnostic study
Translation of a family-based behavioral intervention for adolescent obesity using the RE-AIM framework and common steps from adaptation frameworks
Rodgers, Kristi V, Nayman, Samuel J, Hofschulte, Deanna R., Loncar, Haylee, Kumar, Seema , Lynch, Brian , Rajjo, Tamim , Wilson, Dawn K. , Biggs, Bridget K , Rajjo, Tamim I, Biggs, Bridget K.

Mayo Clinic

Translational Behavioral Medicine | April 13, 2023 | Volume: 13 | Issue: 9 | Pages: 700-709

10.1093/tbm/ibad022 | PMID 37053109 Get It

Abstract Interventions for adolescent weight management that are ready to use in clinical settings are needed to address the obesity epidemic and improve the health and wellbeing of affected adolescents. This report describes the systematic process our team followed to adapt an evidence-based intervention (EBI) for adolescent weight management from its randomized control trial protocol to a package for delivery in a group-based telehealth format within a medical center. The EBI adaptation was clinician initiated, prompted by identified practice needs, and involved collaboration of the clinical team with the EBI developer. The process was guided by the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework and followed key steps for adapting EBIs to new contexts. RE-AIM-aligned adaptations included telehealth delivery and broader inclusion criteria, separate clinical and research evaluation batteries, adaptations to fit the clinical practice, practical fidelity checklists to guide and record session delivery, and continuous quality improvement processes aimed to facilitate program longevity and family engagement. The process culminated in a package of adapted intervention materials deemed by stakeholders as appropriate to the practice and congruent with the EBI model. This report provides a much-needed practical demonstration of the translation of an EBI for adolescent weight management from research protocol to group telehealth delivery in a medical center. Key lessons include the value of clinician-researcher collaboration, the breadth of resources needed to adapt EBIs for real-world delivery, and the importance of considering delivery context in implementation and evaluation decisions, including defining inclusion criteria, staffing, and outcomes assessments.